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Abstract
Objective: Enhanced cognitive behavior therapy (CBT-E) is a transdiagnostic treat-
ment suitable for the full range of eating disorders (EDs). Although the effectiveness
of CBT(-E) is clear, it is not being used as widely in clinical practice as guidelines rec-
ommend. The aim of the present study was to compare the effectiveness of CBT-E
with treatment as usual (TAU), which was largely based on CBT principles.
Method: We conducted a randomized controlled trial on a total of 143 adult patients
with an ED who received either CBT-E or TAU. The primary outcome was recovery
from the ED. Secondary outcome measures were levels of ED psychopathology, anxi-
ety, and depressive symptoms. Self-esteem, perfectionism, and interpersonal problems
were repeatedly measured to examine possible moderating effects. We explored differ-
ences in duration and intensity between conditions.
Results: After 80 weeks, there were no differences between conditions in decrease
in ED psychopathology, or symptoms of anxiety and depression. However, in the first
six weeks of treatment there was a larger decrease in ED psychopathology in the
CBT-E condition. Moreover, when the internationally most widely used definition of
recovery was applied, the recovery rate at 20 weeks of CBT-E was significantly
higher (57.7%) than of TAU (36.0%). At 80 weeks, this difference was no longer sig-
nificant (CBT-E 60.9%; TAU 43.6%). Furthermore, CBT-E was more effective in
improving self-esteem and was also the less intensive and shorter treatment.
Discussion: With broader use of CBT-E, the efficiency, accessibility and effectivity
(on self-esteem) of treatment for EDs could be improved.
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1 | INTRODUCTION
Prevailing guidelines for the treatment of eating disorders
(ED) endorse cognitive behavior therapy (CBT) as psychological treat-
ment of first choice, especially for bulimia nervosa (BN) and binge-
eating disorder (BED) (Hay et al., 2014; Hilbert, Hoek, & Schmidt,
2017; National Institute for Health and Care Excellence (NICE), 2017;
Yager et al., 2014). The effectiveness of CBT for anorexia nervosa
(AN) is less pronounced, however this should be understood in the
context of similar, somewhat disappointing, outcomes of other thera-
pies for AN (van den Berg et al., 2019; Waller, 2016). CBT-Enhanced
(CBT-E) is a specific form of CBT suitable for the full range of eating
disorder diagnoses (Fairburn, 2008). It is based on a transdiagnostic
theory of the maintaining mechanisms involved in the persistence of
ED, which assumes that most mechanisms are common to all EDs,
rather than being specific for one diagnostic category. According to
this theory, a dysfunctional evaluation of self-worth, overly based on
shape and weight, is central to all eating disorders (Fairburn, Cooper, &
Shafran, 2003). The focused version of CBT-E (CBT-Ef) consists of
interventions to modify this overevaluation of shape and weight. The
treatment protocol can be adjusted when additional maintaining
mechanisms are expected to obstruct change (low self-esteem, clinical
perfectionism, and interpersonal problems). This extended protocol is
known as the “broad” version of CBT-E (CBT-Eb). For both versions of
CBT-E, two variants of intensity have been developed involving either
20 sessions in 20 weeks for patients who are not significantly under-
weight (body mass index (BMI) >17.5), or 40 sessions in 40 weeks for
patients who are significantly underweight (BMI <17.5). On account
of its transdiagnostic reach, CBT-E has an advantage over other CBT
protocols for the otherwise specified feeding and eating disorder
(OSFED). A systematic review in 2018 showed robust evidence for
the effectiveness of CBT-E in adult patients with an ED, especially
those with BN, BED, and OSFED (de Jong, Schoorl, & Hoek, 2018).
Although there is clear evidence of the effectiveness of CBT(-E)
for EDs, it is not being used as widely in clinical practice as guidelines
recommend (Tobin, Banker, Weisberg, & Bowers, 2007; von Ranson &
Robinson, 2006). In a 2018 Dutch study among 139 clinicians who
delivered CBT for eating disorders, the use of specific CBT techniques
was below the level one would expect if following treatment manuals
(Mulkens, de Vos, de Graaff, & Waller, 2018). Moreover, there are no
empirical data about the content, effectiveness and efficiency of
treatments as usual (TAU). Independent ED experts in Belgium and
the Netherlands have estimated that TAU for EDs is probably more
intensive, longer-term and less effective than CBT-E (de Jong et al.,
2016). If time-limited CBT-E is indeed at least as effective as TAU for
a broad range of ED patients, then the effectiveness, efficiency and
accessibility of an evidence-based treatment for patients with an ED
could be improved.
Therefore, the primary objective of this study was to assess
whether the focused version of CBT-E for patients with an ED and a
BMI >17.5 was more optimal in terms of a higher percentage of
recovery compared to TAU. The secondary objectives were to assess
whether CBT-E was more effective in reducing important aspects of
ED psychopathology, and comorbid symptoms of anxiety and depres-
sion. Although the effect of the focused version of CBT-E was
assessed, according to the rationale of the broad version of CBT-E,
participants with more self-esteem problems, perfectionism and inter-
personal problems at baseline were expected to respond less on the
focused version of CBT-E. Consequently, these variables were exam-
ined as possible moderating variables. Finally, to test the hypothesis
that CBT-E is a less intensive and shorter treatment than TAU, possi-




A multicenter randomized controlled trial (RCT) was conducted at
three specialized eating disorder treatment centers in three different
regions in the Netherlands. Participants were randomized into two
groups (CBT-E vs. TAU), stratified by type of ED (AN, BN, BED,
OSFED), gender (male/female), BMI range (17.5–20, 20–25, 25–30,
30–40), and psychotropic medication (yes/no). They were all assessed
pretreatment (T0) and at 6 weeks (T1), 20 weeks (T2), 40 weeks (T3),
and 80 weeks (T4), resulting in a 2 (treatment) × 5 (time) repeated
measures factorial design. Given the nature of the psychological treat-
ment, neither the therapists nor participants were blinded for the treat-
ment given. Ethical approval was obtained from the Institutional Review
Board of Leiden University Medical Centre (NL39205.058.12). The trial
was also registered in the Netherlands Trial Register (NTR4485). For
details of the rationale, design, methods, and procedure, we refer to de
Jong et al. (2016).
2.2 | Recruitment
The patient sample (N = 143) was recruited at three specialized
departments for eating disorders: PsyQ/Parnassia Psychiatric Institute
in The Hague, PsyQ/Lentis Psychiatric Institute in Groningen, and
Rintveld/Altrecht Mental Health Institute in Zeist. Figure 1 shows the
CONSORT flow diagram. The inclusion criteria were: having an ED
that required treatment (determined using SCID-I) (First, Spitzer, Gib-
bon, & Williams, 1996; van Groenestijn, Akkerhuis, Kupka,
Schneider, & Nolen, 1998); aged 18 years or older; a BMI >17.5 and
<40 (because of possible medical complications); and giving written
informed consent after receiving a detailed description of the study.
The exclusion criteria were: prior CBT-E or very similar treatment
(N = 2); a coexisting general psychiatric disorder that precluded eating
disorder-focused treatment (N = 9); medical instability or pregnancy
(N = 5); intellectual disability (N = 0); insufficient command of the
Dutch language to fill in the research questionnaires (N = 3); ongoing
psychiatric treatment (except for antidepressant or attention deficit
hyperactivity disorder medications) (N = 4) or not being able to attend
the scheduled therapy sessions (N = 24).
718 DE JONG ET AL.
2.3 | Treatments
2.3.1 | Enhanced cognitive behavior therapy
(CBT-E)
CBT-E is psychological treatment of 20 sessions, preceded by one
preparatory session and followed by one review session 20 weeks
after treatment. The sessions were held twice a week for the first
4 weeks, weekly for the next 10 weeks, and then biweekly in the last
6 weeks. CBT-E is personalized to match the eating disorder psycho-
pathology of the individual patient. In this study the focused version
was used for patients with a BMI >17.5. Up to three additional ses-
sions with significant others could be planned. A detailed manual in
Dutch was developed based on the CBT-E protocol (Fairburn, 2008)
and was used by the participating therapists.
2.3.2 | Treatment as usual
Because there are no empirical data about TAU in the Netherlands,
clinician teams were asked about the content, intensity and duration
of their TAU. The usual treatment given at the participating locations
was based on CBT principles, given individually or in a group and con-
taining elements of existing CBT treatment protocols (Dingemans,
2005; Vanderlinden, Pieters, Probst, & Norré, 2011). Depending on
the center's treatment policy, this varied from low-intensity care
(weekly sessions) to high-intensity care, which consisted of several
group sessions a day for 2–4 days per week, and sometimes sup-
plemented with individual sessions for coexisting psychopathology.
The duration of the treatment was variable. Quite often more than
one discipline (psychologist, dietitian, and psychiatrist) was involved in
providing treatment. The type of treatment provided was registered.
F IGURE 1 CONSORT flow
diagram.
*Operationalization of “treated as
intended” differs between
conditions [Color figure can be
viewed at wileyonlinelibrary.com]
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2.4 | Therapists and treatment integrity
All the CBT-E therapists were psychologists, psychiatrists, registered
nurses or social workers. They had at least 2 years of experience as a ther-
apist in the field of EDs and had worked for at least 2 years according to
CBT principles. CBT-E therapists in the participating centers were trained
by the founder of CBT-E, Professor Christopher Fairburn, and had
20 supervision sessions via videoconferencing from his co-worker, Profes-
sor Zafra Cooper. All the CBT-E therapists treated at least three ED
patients with CBT-E under supervision before entering the trial. All the
TAU therapists were psychologists/psychiatrists or registered nurses/
social workers who had at least 2 years of experience as therapists in the
field of EDs. TAU therapists had regular (mostly weekly), standard, local
collegial consultation led by experienced eating disorder clinicians.
The quality of delivery of CBT-E was assessed by independent
raters (after an online CBT-E training) who listened to the recorded
sessions. In general, two recorded sessions for every CBT-E patient
were randomly selected (from, respectively, stages 1/2 and stages
3/4). The use of specific interventions according to the treatment
manual was scored on several 3-point Likert scales reflecting phase-
specific interventions and the use of interventions outside the scope
of CBT-E. This resulted in a total score for treatment adherence
(0–25%, 25–50%, 50–75%, 75–100%). Of 121 recorded sessions,
52 were double-rated to assess interrater reliability. For interrater reli-
ability, Gwet's agreement coefficient (Gwet, 2008) with linear weights
was calculated as an alternative to Cohen's Kappa for ordinal data
(which is known to lead to paradoxical results when there is high
agreement among raters) (Feinstein & Cicchetti, 1990; Warrens,
2010). There were five raters, one of whom was part of the rating pair
on all occasions. This led to four rating pairs.
2.5 | Assessment
Data were obtained via online questionnaires (using SurveyMonkey),
with the exception of the SCID-I ED section, which was conducted by
telephone.
2.5.1 | Screening and primary treatment outcome
Structured clinical interview for DSM axis-I disorders (SCID-I)
SCID-I (First et al., 1996; van Groenestijn et al., 1998) is a structured
interview used to assess the presence of an ED. Because SCID-I only
covers DSM-IV AN, BN and EDNOS-BED, skip rules were changed or
omitted, and parts of the Eating Disorder Examination (EDE)
(Fairburn, Cooper, & O'Connor, 2008) were added in order to diag-
nose DSM-5 AN, BN, BED and OSFED (Smink, van Hoeken,
Oldehinkel, & Hoek, 2014).
Web Screening Questionnaire for common mental disorders (WSQ)
The WSQ (Donker, van Straten, Marks, & Cuijpers, 2009) was used to
screen for Axis-I disorders.
2.5.2 | Secondary study parameters
The Eating Disorder Examination-Questionnaire (EDE-Q)
The EDE-Q (van Furth, 2000) is a self-reported measure of ED psy-
chopathology. Three outcome variables were created from the
EDE-Q: (a) severity of ED features as measured by the mean EDE-Q
item score (continuous), (b) a recovery rate defined as a global EDE-Q
score <1 standard deviation (SD) above community mean (categorical)
(an internationally often used measure (Dalle Grave, Calugi,
Sartirana, & Fairburn, 2015; Wade, Byrne, & Allen, 2017)), i.e., ≤2.77
(Mond, Hay, Rodgers, & Owen, 2006), (c) a global EDE-Q score
≤2.77 + the reliable change index using Jacobson and Truax's method
(Jacobson & Truax, 1991) assuming a test-retest correlation of .76
(Reas, Grilo, & Masheb, 2006). A change greater than 1.41 was consid-
ered as reliable change.
Mood and Anxiety Symptom Questionnaire (MASQ)
The MASQ (de Beurs, van Hemert, & Goekoop, 1991) was used to
assess the severity of symptoms of anxiety and depression.
Treatment duration
To measure treatment intensity and duration, treatment minutes (reg-
istered by the therapists) of every participant were collected between
T0-T1, T1-T2 and T2-T3.
2.5.3 | Moderating variables
The Rosenberg Self-Esteem Scale (RSE) (Rosenberg, 1965) is a widely-
used instrument used to assess global self-esteem. A higher score
refers to a better self-esteem; the Frost Multidimensional Perfectionism
Scale (FMPS) (Frost, Heimberg, Holt, Mattia, & Neubauer, 1993) was
used to assess perfectionism, and the Inventory of Interpersonal Prob-
lems (IIP-32) (Barkham, Hardy, & Startup, 1996) was used to measure
interpersonal problems.
2.6 | Power and sample size
In order to detect an absolute difference in recovery rates from ED of
25% (CBT-E: 50% vs. TAU: 25%), a sample size of 66 patients per
treatment condition was required to provide 80% power at two-sided
p <.05 (intention-to-treat analysis). This means that at least
132 patients were needed for this study.
2.7 | Randomization
Randomization took place after screening of the inclusion/exclusion
criteria and signing of the informed consent. Stratified randomization
was achieved by generating a separate block for each combination of
covariates (i.e., type of ED, gender, BMI range, and use of psychotro-
pic medication) and assigning participants to the appropriate block of
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covariates. After the research assistant has allocated a participant to
one of the strata, participants were assigned to CBT-E or TAU using a
permuted block randomization list, based on a computer generated
outcome, blinded to the research assistant until the allocation to one
of the strata.
2.8 | Statistical methods
Pretreatment differences between conditions and between partici-
pants who completed the intended treatment and those who did not,
were analyzed using t tests and Pearson's chi-squared tests or Fisher's
exact tests (if necessary).
2.8.1 | Intention-to-treat analysis
Primarily, generalized estimating equations (GEE) were used to ana-
lyze the repeated measurement data for the presence of an eating dis-
order (SCID-I) at T0, T2, and T4. The model consisted of main effects
for time and type of treatment, as well as their interaction. Linear
mixed models were used to analyze the repeated measurement data
for eating disorder psychopathology (EDE-Q), interpersonal problems
(IIP-32), perfectionism (FMPS), self-esteem (RSE), lack of positive
affect, somatic arousal, and negative affect at all five time points. The
fixed part of each model consisted of main effects for treatment and
time, as well as their interaction. Time was included in the analyses as
a categorical variable, with the baseline measurement as reference
category. The random part of each model contained a random inter-
cept and a random slope for time, which were assumed to be corre-
lated. For SCID-I and EDE-Q, it was investigated whether there was
any difference in time effect between the three treatment locations,
by incorporating a fixed effect for location and an interaction between
location and time. Restricted maximum likelihood estimation was used
in all mixed models. When an overall F test indicated the presence of
a significant time x treatment interaction, fixed effects were reported
for all parameters.
Mixed models were used to investigate the possible moderation
of RSE, FMPS, and IIP-32 baseline scores on the time × treatment
interaction in the analysis concerning EDE-Q, by including an interac-
tion between the already present time × treatment interaction and
RSE, FMPS, and IIP-32, respectively.
2.8.2 | Per protocol analysis
In an ITT analysis, the effect of being assigned to a specific treatment
is estimated, irrespective of whether or not participants started or
completed the treatment. To estimate the true effect of the experi-
mental condition taking into account effects of nonadherence, a per-
protocol (PP) analysis was conducted (Oncioiu, Franchetti-Pardo, Vir-
tanen, Faggiano, & Galanti, 2017). For the PP analysis, not receiving
CBT-E as intended was defined as premature termination of
treatment (i.e., patient had received less than 70% of the allocated
treatment, <14 of the 20 sessions), or when additional treatment for
the ED or comorbid psychopathology was provided. As there was no
manualized protocol for TAU as control group, not receiving TAU as
intended was defined as termination of the indicated treatment
before T2, either against the therapist's advice or when participants
were transferred to another department before T2 for another
treatment as originally intended. GEE and mixed models were
repeated for participants who completed the intended treatment
and only findings that deviated from previous findings in the
intention-to-treat analyses will be reported. Subsequently, group
differences in recovery rates (based on SCID-I diagnosis, EDE-Q
≤2.77 and EDE-Q ≤2.77 + reliable change index; Jacobson & Truax,
1991) were analyzed at 20 and 80 weeks using Pearson's chi-
squared tests. Analyses regarding recovery (based on the EDE-Q)
were repeated, after omitting participants with scores below the
cut-off at baseline (EDE-Q ≤2.77). Differences between conditions
in treatment intensity (T0-T1, T1-T2, T2-T3, and T0-T3) were ana-
lyzed using Mann–Whitney U test.
3 | RESULTS
3.1 | Patient sample
A total of 143 participants were enrolled from three Dutch mental
health centers between 2013 and 2016 (89 from PsyQ/Parnassia Psy-
chiatric Institute in The Hague, 34 from PsyQ/Lentis Psychiatric Insti-
tute in Groningen, and 20 from Rintveld/Altrecht Mental Health
Institute in Zeist). Their diagnoses were as followed: 13 AN; BMI
range 17.1–19.0 (9.1%), 50 BN; BMI range 18.8–39.3 (35%), 38 BED;
BMI range 20.1–41.2 (26.6%) and 42 OSFED; BMI range 18.4–38.7
(29.4%). 71 were randomized to CBT-E and 72 to TAU. Except for age
(t(133.83) = −2.11, p = .04, d = 0.35), there were no significant differ-
ences in relevant baseline variables between the two treatment condi-
tions and between the three locations. The demographic
characteristics of the sample are summarized in Table 1. Given the
recovery cut-off for the EDE-Q (Mond et al., 2006), there were nine
participants with scores below the cut-off at baseline in the total sam-
ple of the TAU group, and seven in the CBT-E group.
3.2 | Treatment integrity
Due to a malfunctioning voice recorder, 8% of the recorded interview
sessions were missing. According to the nomenclature proposed by
Landis and Koch (1977), the interrater reliability was fair for the first
couple (AC2 = .36), and almost perfect for the second and third cou-
ples (AC2 = .83 respectively .86). For the fourth couple, there was an
absolute agreement on all ratings, which meant we could not calculate
Gwet's AC (theoretically, however, this AC was 1.00). Ninety-three
percentage of the recorded sessions were scored in the highest rating
range (75–100%), indicating there was good delivery of CBT-E.
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3.3 | Characteristics of TAU
The type of treatment provided in TAU was registered (see Table 2).
All treatments were based on CBT principles (i.e., registrations, cogni-
tive techniques and behavioral experiments). However, there was a
great variety in interventions, intensity, duration, setting and treat-
ment of comorbidity.
TAU differed from CBT-E in two specific ways: (a) the content of
the group treatments in TAU was based on CBT principles for specific
diagnoses (for example; BN group or BED group) as opposed to CBTE
that is a (individual) transdiagnostic treatment. (b) The content of indi-
vidual treatments in TAU is best described as more freely applied CBT
compared to manual based CBT-E.
In addition to CBT for eating disorder psychopathology, a variety
of additional interventions were integrated in TAU, including; nutri-
tional interventions and psychomotor therapy (i.e., body awareness,
emotion regulation). Furthermore, 29 % of the treatments in TAU
included interventions for comorbid psychopathology (i.e., EMDR for
posttraumatic stress disorder, CBT for depression and schema therapy
for personality disorder). In most treatments (85%), more than one dis-
cipline was involved.
3.4 | Differences between participants treated as
intended versus not treated as intended
In the CBT-E group, 17 participants (24%) did not complete treatment
as intended; in the TAU group, this involved 15 participants (21%). The
32 participants who were not treated as intended did not differ from
the 111 patients who completed treatment in their baseline measure-
ments on the EDE-Q, RSE, FMPS, and IIP-32, their SCID diagnosis,
treatment location or treatment condition (results available on request).
3.5 | Intention-to-treat analysis
There was no significant interaction between group and time regard-
ing recovery from SCID diagnosis (OR = 1.01, 95% CI [0.81, 1.26]).
However, there was a main effect for time (OR = 2.33, 95% CI [1.98,
TABLE 1 Baseline characteristics of the patient sample
CBT-E TAU
(N = 71) (N = 72)
M SD M SD
Age (years) 28.9 8.6 26.2 6.9
Duration of eating disorder
in years (N = 123)
9.2 8.5 7.7 6.3
BMI 26.3 7.0 25.6 6.7
EDE-Q global score 4.1 1.0 4.0 1.1
FMPS 86.5 22.2 83.1 22.2
IIP-32 1.5 0.6 1.3 0.6
RSES 22.3 5.1 23.6 5.2
MASQ-PA 2.4 0.7 2.3 0.7
MASQ-SA 1.8 0.6 1.9 0.7
MASQ-NA 2.7 0.8 2.8 0.8
WSQ 3.8 2.2 3.4 2.1
N % N %
Female 69 97.2 68 94.4
Currently in a relationship 32 45.1 31 43.1
Children 16 22.5 11 15.3
Live with parents 11 15.5 10 13.9
Anorexia nervosa 5 7.0 8 11.1
Bulimia nervosa 27 38.0 23 31.9
Binge-eating disorder 18 25.4 20 27.8
Other specified feeding
and eating disorders
21 29.6 21 29.2
Binges (during the past
28 days)
51 71.8 53 73.6
Purging (during the past
28 days)
30 42.2 28 38.9
Abbreviations: CBT-E, cognitive behavior therapy enhanced; EDE-Q,
Eating Disorder Examination-Questionnaire; F-MPS, Frost
Multidimensional Perfectionism Scale; IIP-32, Inventory of Interpersonal
Problems; MASQ, Mood and Anxiety Questionnaire; NA, negative affect;
PA, positive affect; RSE, Rosenberg Self-Esteem Scale; SA, somatic
anxiety; TAU, treatment as usual; WSQ, Web Screening Questionnaire
for common mental disorders.












The Hague (43) 43 8 24 11 40 14
Groningen (19) 19 5 5 9 11 5
Zeist (10) 10 2 4 4 10 2
Total 72 (100%) 15 (21%) 33 (46%) 24 (33%) 61 (85%) 21 (29%)
aCombination of group and individual therapies.
bFor example, dietician, psychologist, psychiatrist, psychomotor therapist.
cIncluding ADHD, depression, personality disorder, PTSS.
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2.74]). Treatment locations did not differ in the overall presence of
SCID diagnoses, nor was there an interaction with the time variable.
Estimates and confidence intervals for this analysis are presented in
Table S1 in the supplementary material.
For EDE-Q, there was a significant main effect for time (F(4, 441)
= 51.66, p <.001) and a significant interaction between group and time
(F(4, 441) = 2.85, p = .02). The fixed effects in Table 3 show that this
effect is particularly significant between T0 and T1. There was no
main effect for location (F(2, 139) = 0.98, p = .38), nor an interaction
effect between time and location (F(8, 433) = 1.06, p = .39). The left
panel of Figure 2 shows the development of EDE-Q scores over time
for both groups. Parameter estimates for fixed effects can be found in
Table 3.
For RSE, a main effect was present for time (F(4, 452) = 20.14,
p <.001) as well as a group x time interaction (F(4, 452) = 2.49, p =
.04). Fixed effects are presented in Table 3. In general, RSE showed a
positive trend over time, and CBT-E showed it had an extra time
effect on self-esteem. The development of RSE scores over time for
both groups is depicted in the right panel of Figure 2, and parameter
estimates are reported in Table 3.
For FMPS, only a significant main effect for time was found
(F(4, 446) = 5.03, p <.001), but no significant group × time interaction
(F(4, 446) = 1.71, p = .15).
For IIP-32, significant main effects were found for time (F(4, 445) =
13.17, p < .001) and group (F(1, 141) = 4.19, p = .04), but no group ×
time interaction (F(4, 445) =1.73, p = .14).
For the MASQ, there was a main effect for time regarding negative
affect (F(4, 456) = 17.57, p <.001), positive affect (F(4, 456) = 13.30,
p <.001) and anxiety (F(4, 456) = 11.84, p < .001), but no group × time
interactions were found for negative affect (F(4, 456) = 0.34, p = .85),
positive affect (F(4, 456) = 0.62, p = .65) or anxiety (F(4, 456) = 0.67,
p =.61). For all seven outcome measures, test statistics from the overall
F tests are presented in Table S2 in the supplementary material.
TABLE 3 Fixed effects for mixed models with EDE-Q and RSE
Estimate SE df t p
EDE-Q
Intercept 4.07 0.12 441 33.23 <.001
Time
6 weeks −0.49 0.10 441 −5.00 <.001
20 weeks −1.20 0.18 441 −6.68 <.001
40 weeks −1.28 0.17 441 −7.49 <.001
80 weeks −1.76 0.19 441 −9.24 <.001
Condition1 0.06 0.17 141 0.36 .72
Condition × time
6 weeks −0.31 0.14 441 −2.22 .03
20 weeks −0.29 0.25 441 −1.18 .24
40 weeks −0.42 0.24 441 −1.77 .08
80 weeks 0.11 0.26 441 0.43 .67
RSE
Intercept 23.57 0.61 452 38.64 <.001
Time
6 weeks 0.41 0.47 452 0.88 .38
20 weeks 1.70 0.61 452 2.79 .01
40 weeks 2.37 0.80 452 2.94 <.001
80 weeks 3.73 0.84 452 4.43 <.001
Condition1 −1.27 0.87 141 −1.47 .14
Condition × time
6 weeks 1.64 0.66 452 2.48 .01
20 weeks 2.30 0.86 452 2.69 .01
40 weeks 2.36 1.12 452 2.10 .04
80 weeks 2.29 1.15 452 1.99 .048
Abbreviations: EDE-Q, Eating Disorder Examination Questionnaire;
Condition, RSE, Rosenberg Self-Esteem Scale.
1Condition = CBT-E (cognitive behavior therapy enhanced).
F IGURE 2 EDE-Q and RSE scores for the CBT-E and TAU groups.
Abbreviations: CBT-E, cognitive behavior therapy enhanced; EDE-Q, Eating Disorder Examination Questionnaire; RSE, Rosenberg Self-Esteem
Scale; TAU, treatment as usual
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3.6 | Per protocol analysis
The recovery rates at 20 weeks (end of CBT-E) and 80 weeks, as
measured with the SCID were comparable for both treatment condi-
tions (see Table 4). When using the international EDE-Q recovery
norm (global sore ≤1 SD above community mean; i.e., ≤2.77, and
EDE-Q ≤2.77 + RCI), the posttreatment recovery rates for CBT-E at
20 weeks (57.7% and 46.2%) were significantly higher than that for
TAU (36.0% and 26.0%). However, at 80 weeks this difference was
no longer significant.
For IIP, the main effect for treatment was nonsignificant
(F(1, 109) = 1.69, p = .20), but the time x treatment effect became sig-
nificant (F(4, 381) = 3.29, p = .01). CBT-E shows an extra decline at
20 and 40 weeks compared to TAU. The overall F test statistics and
fixed effects for IIP in the per protocol analysis are presented in the
supplementary material, respectively in Tables S3 and S4.
3.7 | Moderators
The time × treatment interaction for EDE-Q global was moderated by
the RSE baseline score (F(4, 433) = 2.56, p = .04). Between baseline
and 6 weeks, participants receiving CBT-E reported an additional
decrease in EDE-Q scores, when the RSE baseline score was higher.
Overall F test statistics and fixed effects for this moderator analysis
are presented in Tables S5 and S6 in the supplementary material.
3.8 | Treatment intensity
Significant differences in treatment intensity between T0–T1 and T2–T3
were found. Between T0 and T1, CBT-E was more intensive
(Mann–Whitney: p <.001), while between T2–T3 TAU consisted of more
treatment minutes (Mann–Whitney: p <.001). Overall, between T0–T3,
CBT-E appeared a significantly less intensive treatment than TAU (Mann–
Whitney: p = .01) (see Table 5 and Figure S1 in the supplementary
material).
4 | DISCUSSION
The first two aims in this study were to compare the focused version of
CBT-E with TAU for patients with an ED (BMI >17.5) in terms of differ-
ences in recovery from the ED, and reduction of important aspects of
ED psychopathology and comorbid symptoms of anxiety and depression.
Systematic registration of TAU showed that all these treatments were
based on CBT principles, however with a great variation in interventions,
setting, treatment intensity, number of involved disciplines, and treat-
ment of comorbidity. After 80 weeks, there were no differences
between conditions in recovery from the ED, or in decrease in global ED
psychopathology and comorbid symptoms of anxiety and depression.
However, significant differences in effect were found in the first six
TABLE 4 Participants treated as intended; rates at 20 and 80 weeks for CBT-E and TAU using three different definitions of recovery
At 20 weeks At 80 weeks
CBT-E TAU Test statistics CBT-E TAU Test statistics
N % N % χ2(1) p N % N % χ2(1) p
Including participants with scores below the cut-off at baseline
Remitted (SCID) 22 42.3 17 32.7 1.03 0.31 32 64.0 23 50.0 1.92 0.17
EDE-Q ≤2.77 30 57.7 18 36.0 4.81 0.03 32 62.7 22 50.0 1.56 0.21
EDE-Q ≤2.77 and RCI 24 46.2 13 26.0 4.48 0.03 30 58.8 18 40.9 3.03 0.08
Excluding participants with scores below the cut-off at baseline
Remitted (SCID) 22 42.3 17 32.7 1.03 0.31 32 64.0 23 50.0 1.92 0.17
EDE-Q ≤2.77 26 55.3 14 31.8 5.09 0.03 28 60.9 17 43.6 2.53 0.11
EDE-Q ≤2.77 and RCI 23 48.9 12 27.3 4.51 0.03 26 56.5 17 43.6 1.41 0.23
Abbreviations: CBT-E, cognitive behavior therapy enhanced; TAU, treatment as usual.
RCI (Reliable Change Index) was based on a test–retest correlation of .76 and baseline pooled SD of 1.037 for both groups. Bold face values are significant.
TABLE 5 Treatment intensity of participants treated as intended
CBT-E TAU
Mdn IQR Mdn IQR
T0–T1a
Treatment intensity (min) 560 148 270 255
T1–T2
Treatment intensity (min) 587 143 630 822
T2–T3a
Treatment intensity (min) 87 125 570 1,100
Total (T0–T3)a
Treatment intensity (min) 1,272 249 1,860 2,280
Abbreviations: CBT-E, cognitive behavior therapy enhanced; IQR,
interquartile range; Mdn, median; TAU, treatment as usual.
aSignificant Mann–Whitney U test.
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weeks of treatment, with the CBT-E condition showing a larger decrease
in ED psychopathology. Moreover, when the internationally most widely
used definition of recovery was applied, the recovery rate at 20 weeks
of CBT-E was significantly higher (57.7%) than of TAU (36.0%). At
80 weeks (60 weeks follow-up for the CBT-E condition), this difference
was no longer significant (CBT-E 60.9%; TAU 43.6%). Compared to other
RCTs examining CBT-E with similar transdiagnostic samples (Fairburn
et al., 2009; Fairburn et al., 2015) these recovery results are slightly
lower, although the differences are small and direct comparisons are
complicated by differences in study characteristics, instruments and data
analysis. Furthermore, 24% of the participants in the present study did
not complete CBT-E as intended which is comparable to the Fairburn
et al. study (2009) with a drop-out rate of 22.1%. CBT-E for non-
underweight patients with an ED is known to be more efficacious than
interpersonal psychotherapy (Fairburn et al., 2015) and psychoanalytic
therapy (Poulsen et al., 2014) in terms of a faster treatment response.
This is the first study showing that CBT-E also reaches these results
faster than a less formal protocol of CBT (i.e., TAU). Although in this
study therapists' considerations and exact treatment interventions (in the
TAU group) were not registered, earlier studies have shown that in clini-
cal practice, the integrity of applying CBT techniques (even in CBT eating
disorder therapies) is below the level one would expect if treatment man-
uals were followed (Mulkens et al., 2018; Waller, Stringer, & Meyer,
2012). Together with the clear focus of CBT-E on early behavioral
change, it is likely that offering twice-weekly sessions at the start could
explain the faster response to CBT-E in the first phase of treatment.
The third aim was to examine the possible moderating effects of
self-esteem, perfectionism and interpersonal problems. No differences
between conditions were found on reduction of perfectionism or
interpersonal problems, but CBT-E proved more effective in improv-
ing self-esteem than TAU. While it is often thought that amelioration
of psychopathology symptoms during psychotherapy is associated
with the enhancement of self-esteem (Fennell & Jenkins, 2004), the
precise mechanisms underpinning these effects are not known
(Linardon, Kothe, & Fuller-Tyszkiewicz, 2019). However, some poten-
tial explanations for the overall superior effect of CBT-E on self-
esteem can be hypothesized. The main focus of CBT-E is to modify
the over-evaluation of shape and weight by establishing self-worth
based on other aspects (friends, work, hobbies, etc.). It is assumed that
by enhancing attention to other domains of self-worth, self-esteem
can be improved (Fairburn, 2008). Interestingly, the difference in
effect on self-esteem was found to be largest in the first six weeks of
treatment, which were not explicitly focused on modifying the over-
evaluation of shape and weight. However, this first phase is intensive
(twice-weekly sessions) and focuses mainly on understanding the pro-
cesses that maintain the eating problems and on early behavioral
change. This approach could also have secondary effects. For exam-
ple, creating hope that change is possible, can enhance self-
confidence and self-esteem (Fairburn, 2008).
Moreover, in the CBT-E condition, changes in ED psychopathology
during the first six weeks of treatment, were moderated by self-esteem.
When, at baseline, self-esteem problems were less severe, there was an
additional effect of CBT-E on decreasing ED psychopathology in this
first phase. This enhancing effect of self-esteem disappears from week
20 onwards. Changes in ED psychopathology were not moderated by
the degree of perfectionism or interpersonal problems. This means that,
in this study, we found no support for the hypothesis that more severe
self-esteem problems, higher levels of perfectionism, or more interper-
sonal problems (the supposed additional maintaining mechanisms of
ED) would obstruct long-term improvement and would therefore need
extra attention in an extended protocol.
The last aim of this study was to explore possible differences in
the duration and intensity of CBT-E and TAU. Although for non-
underweight ED patients, the current standard is to administer around
20 sessions of CBT in 20 weeks, there are no studies that have
mapped the duration and intensity of TAU. In general, CBT-E was
completed in 20 weeks and was significantly more intensive for the
first six weeks of treatment, whereas TAU was significantly more
intensive between 20 and 40 weeks of treatment. Overall, (between
start and 40 weeks of treatment) CBT-E was significantly less inten-
sive, which can have a major effect on health care costs.
This study has several limitations. The SCID was conducted by
the research assistant. She was not blind for condition or previous
SCID outcome because the outcome of the SCID was necessary for
randomization and there was only one research assistant available.
However, the EDE-Q could be administered by Survey Monkey
which had the benefit of unbiased data collection. Although the con-
tent of TAU was registered, there was no detailed description. For
example, the way self-esteem was addressed in TAU was unclear,
which complicates interpretation of the differences in effect on self-
esteem between the two conditions. Furthermore, therapists and
patients may be more interested in the effect of an intervention
delivered as intended rather than in the effect of the assigned inter-
vention. The results of our PP analysis closely replicated the results
of our ITT analysis. However, as there is no univocal definition of
TAU, and therefore no manualized protocol for the control group,
TAU as intended had to be defined somewhat different from CBT-E
as intended with at least 14 sessions as a minimal requirement for
attendance. Consequently, results have to be interpreted with cau-
tion. Moreover, because of the nature of the RCT, TAU was not lim-
ited in its duration. Therefore, we cannot draw any conclusions on
the follow-up results of TAU. Lastly, this study was restricted to par-
ticipants with a BMI >17.5. Although it included a small percentage
of participants with AN, we cannot generalize these findings to
patients with AN.
A recommendation can be made for future research: although this
study strengthens the evidence on the effectiveness of CBT-E, little is
known about the working mechanisms. Studies on these mechanisms
in CBT-E could strengthen its theoretical foundations.
5 | CONCLUSION
After 80 weeks CBT-E and TAU both have comparable effects on
patients' recovery from an ED and show a decrease of ED psychopa-
thology, however, we found CBT-E reaches these results faster and is
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superior in enhancing self-esteem with significantly fewer sessions
and within a shorter time. With a broader implementation of CBT-E in
clinical practice, the efficiency, accessibility and effectivity (on self-
esteem) of treatment for patients with an ED could be improved.
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